iCAD to highlight AI for tomosynthesis at ECR
iCAD plans to highlight its artificial intelligence (AI) software for digital...Read more on AuntMinnie.comRelated Reading: iCAD touts clinical results with Xoft Axxent brachytherapy iCAD highlights study results of DBT software iCAD touts study on radiation therapy savings iCAD scores Chinese OK for balloon applicators iCAD to highlight Xoft clinical results at AAPM
This study aimed to compare external radiation (beam radiation) and internal radiation as a single radiation therapy to advanced HCC patients (TNA stage III and IV according to the derived AJCC Stage, 6th edition) stratified by other risk factors, based on the data collected from the Surveillance, Epidemiology and End Results (SEER) national database. In this cohort study, we mainly clarified the following three points: 1. Choices of radiation therapy for advanced HCC patients vary in demographic and clinical factors. Among these, TNM classification is the key factor. 2. Internal radiation provides a better prognosis in bo...
CONCLUSIONS: The first results of treatment with the Axxent eBT device are promising, as no recurrences have been observed and toxicity is very low. eBT is a good alternative for treating cervical cancer in centers without access to conventional HDR. PMID: 31183970 [PubMed - as supplied by publisher]
Publication date: Available online 4 June 2019Source: European UrologyAuthor(s): Sebastian Berg, Alexander Cole, Quoc-Dien Trinh
Conclusions: DIR is increasingly important in RT applications, from planning to toxicity prediction. DIR is routinely used to reduce the workload of contour propagation. However, its use for complex dosimetric applications must be carefully evaluated by combining quantitative and qualitative analyses. PMID: 31155990 [PubMed - as supplied by publisher]
Cancer Gene Therapy, Published online: 03 June 2019; doi:10.1038/s41417-019-0104-zHITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
Conclusions: Percutaneous CT fluoroscopy-guided permanent seed brachytherapy is a safe, efficacious, and cost effective primary and salvage treatment for lung cancer. CT-fluoroscopy resources are readily available in the community and are an effective alternative to stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT)/proton beam, radiofrequency ablation (RFA), and cryoablation (CA). Percutaneous CT fluoroscopy-guided permanent seed brachytherapy has an equivalent or better local control rate, a lower resource cost, and a far lower integral radiation dose than other therapies. We believe...
Conclusion: The proposed QSM-based technique relies on the standard MR pulse sequences and visualize the conventional MR-invisible metallic devices with CT-like positive contrast solely through post-processing. Upon in-vivo validation of the technique, QSM may have the potential to replace CT for an MR-only guided radiation therapy.
. PMID: 31151120 [PubMed - as supplied by publisher]
To the Editor: We thank Drs Yadav and Gupta for their interest in our trial of 3-fraction compressed accelerated partial-breast irradiation (APBI) delivered with brachytherapy applicators1,2 and his letter entitled “Radiation Therapy De-escalation or Over-treatment?” regarding our report. We would like to be clear that although partial breast radiation therapy does represent a de-escalation in the scope of treatment (relative to whole breast radiation therapy), we do not view our compressed dose schedule a s a “de-escalation”—rather the dose being delivered is expressly calculated to be bioequ...
To evaluate the biochemical freedom from failure (bFFF) by risk group and treatment modality and the predictive factors of bFFF by risk group in patients with prostate cancer undergoing permanent seed implantation (PI) with or without external beam radiation therapy (EBRT) in a nationwide prospective cohort study (Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 [I-125] Seed Implantation) in Japan during the first 2 years.
Conclusions: BT was effective as a definitive treatment modality for prostate cancer, and its endpoints and toxicities were comparable to those of the main series in the literature.